|Catalogue Number||Nominal Thickness (mm)||Nominal Width (cm)||Nominal Length (cm)|
CONTRAINDICATIONS: Patients with hypersensitivity to chlorhexidine or silver; reconstruction of cardiovascular defects; reconstruction of central nervous system or peripheral nervous system defects; pre-term and neonatal populations. WARNINGS: Use with caution in patients with methemoglobinopathy or related disorders. When used as a temporary external bridging device, use measures to avoid contamination; the entire device should be removed as early as clinically feasible, not to exceed 45 days after placement. When unintentional exposure occurs, treat to avoid contamination or device removal may be necessary. Improper positioning of the smooth non-textured surface adjacent to fascial or subcutaneous tissue will result in minimal tissue attachment. POSSIBLE ADVERSE REACTIONS: Contamination, infection, inflammation, adhesion, fistula formation, seroma formation, hematoma and recurrence.
Sizing, availability and pricing varies by country.
Please check with your Gore representative for availability.